Neogen (NEOG) to Announce Earnings on Thursday

Neogen (NASDAQ:NEOG) is expected to be releasing its Q4 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to post earnings of $0.05 per share and revenue of $212.35 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:00 AM ET.

Neogen Price Performance

Neogen stock opened at $9.19 on Wednesday. The stock’s fifty day moving average price is $9.31 and its two-hundred day moving average price is $9.59. Neogen has a one year low of $4.56 and a one year high of $11.43. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. The firm has a market cap of $2.00 billion, a PE ratio of -3.28, a price-to-earnings-growth ratio of 4.18 and a beta of 1.80.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Weiss Ratings cut Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday. Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Neogen currently has an average rating of “Hold” and an average price target of $10.67.

Institutional Investors Weigh In On Neogen

Several institutional investors and hedge funds have recently added to or reduced their stakes in NEOG. Cibc World Markets Corp acquired a new position in shares of Neogen during the 4th quarter worth $47,983,000. T. Rowe Price Investment Management Inc. boosted its stake in Neogen by 249.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company’s stock valued at $57,191,000 after buying an additional 5,838,570 shares in the last quarter. Bank of Montreal Can boosted its stake in Neogen by 4,059.4% in the third quarter. Bank of Montreal Can now owns 4,592,218 shares of the company’s stock valued at $26,222,000 after buying an additional 4,481,812 shares in the last quarter. BNP Paribas Financial Markets grew its position in Neogen by 809.8% in the third quarter. BNP Paribas Financial Markets now owns 2,660,884 shares of the company’s stock valued at $15,194,000 after acquiring an additional 2,368,410 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in Neogen by 169.5% in the second quarter. Ameriprise Financial Inc. now owns 3,079,123 shares of the company’s stock valued at $14,718,000 after acquiring an additional 1,936,569 shares during the last quarter. 96.73% of the stock is currently owned by institutional investors.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.